Why it’s critical to seek treatment early for wet age-related macular degeneration
Wet AMD – the leading cause of severe vision loss and legal blindness in people over the age of 651 – can progress rapidly. One of the causes of vision impairment and loss long-term is under treatment. Therefore, receiving treatment for wet macular degeneration early is essential to maintaining your vision and the lifestyle you love.2
The prospect of vision loss can be distressing but the good news is treatment for wet AMD can slow the progression of the disease, help maintain sight and sometimes even improve vision. In fact, when diagnosed and treated early, people with wet macular degeneration may maintain better vision and quality of life.3
Did you know that wet AMD can progress even before symptoms of vision impairment are noticed?3 The truth is even if you’re not experiencing symptoms of vision impairment but you’re living with wet AMD, early and consistent treatment is essential to help maintain long-term health and wellbeing so you can continue to pursue the activities you enjoy.
While treatment affects everyone differently, one type of treatment that can slow the progression of the disease and help protect your vision is known as “anti-VEGF treatment”.4 To learn more about treatment for wet AMD click here (link to Treatment for wet AMD article).
Be sure to connect with your eye doctor early and often to understand the treatment option that is best for you and help manage the progression of your condition.
Schmidt-Erfurth U, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014; 98:1144-1167.
Miller JW, Bagheri S, Vavvas DG. Advances in Age-related Macular Degeneration Understanding and Therapy. US Ophthalmic Rev. 2017;10(2):119-130.
NHS Choices. Macular degeneration – Symptoms. Available at http://www.nhs.uk/Conditions/Macular-degeneration/Pages/Symptoms.aspx. Accessed July 2020.
Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age-related macular degeneration–emerging pathogenetic and therapeutic concepts. Ann Med. 2006;38(7):450-471.